As of 2025-07-06, the Fair Value of Unicycive Therapeutics Inc (UNCY) is -10.31 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.60 USD, the upside of Unicycive Therapeutics Inc is -324.03%.
With the market price of 4.60 USD and our fair value calculation, Unicycive Therapeutics Inc (UNCY) is not a good investment. Investing in UNCY stocks now will result in a potential loss of 324.03%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -2.26 | -10.02 | -18.06 | -30.54 | -36.73 | -19.52 |
| YoY growth | -4.15% | -343.36% | -80.24% | -69.13% | -20.25% | -103.42% |
| Market Cap (mil) | 81.97 |
| P/E | |
| Forward P/E |
| EPS | -2.06 |
| Avg earnings growth rate | -103.42% |
| TTM earnings | -36.73 |